Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Web Editors' Choice 2013

By The Editors - 2013-12-24T19:48:39Z

Photograph by Ron Antonelli/Bloomberg

Company Symbol % Change
7 of 23

Stented to Death

Inserting coronary stents, metal mesh tubes designed to open keep arteries open, is a lucrative procedure for doctors and hospitals that has grown into a $14 billion-a-year business. They're now used routinely in elective patients to prevent heart attacks. What patients often don't know, are the risks that Peter Waldman, Sydney P. Freedberg and David Armstrong report in a series of articles. Their reporting goes from reckless doctors and their patients who died on the operating table to a nationwide view of how stents became a key hospital profit center. They also show the industry's reluctance to admit, despite voluminous evidence, that using stents is ever inappropriate.

Advertisement